Hudson Bay Capital Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$199K Buy
54,001
+33,282
+161% +$124K ﹤0.01% 1106
2025
Q4
$72.5K Buy
+20,719
New +$72.3K ﹤0.01% 1056

Other funds holding APYX

Hudson Bay Capital Management's APYX Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Apyx Medical (APYX) stake by 161% in Q1 2026, buying an estimated $124K and bringing the position to 54,001 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

Hudson Bay Capital Management first reported a position in APYX in Q4 2025 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Hudson Bay Capital Management held 54,001 shares of Apyx Medical worth $199K as of Q1 2026.
  • Hudson Bay Capital Management bought 33,282 Apyx Medical shares in Q1 2026, an estimated $124K.
  • Apyx Medical made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1106 holding.
  • Hudson Bay Capital Management first reported a position in Apyx Medical in Q4 2025 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.